Thomas A. Zalewski's most recent trade in Aquestive Therapeutics Inc was a trade of 100,000 Common Stock done . Disclosure was reported to the exchange on May 18, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Aquestive Therapeutics Inc | Thomas A. Zalewski | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2026 | 100,000 | 100,000 (0%) | 0% | 0 | Common Stock | |
| Aquestive Therapeutics Inc | Thomas A. Zalewski | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2026 | 75,000 | 75,000 | - | - | Non-Qualified Stock Option (right to buy) |